ACAD
32.62
-0.24
-0.73%
AEMD
5.21
-0.09
-1.70%
APRI
0.35
+0.01
+2.94%
ARNA
1.6
-0.03
-1.84%
ATEC
3.83
+0.14
+3.74%
CNAT
2
+0.1
+5.26%
CRXM
0.17
0.00
-1.52%
CYTX
2.06
+0.01
+0.49%
DXCM
91.65
+0.41
+0.45%
GNMK
8.64
-0.11
-1.26%
HALO
9.8
-0.02
-0.20%
ILMN
170.42
-1.79
-1.04%
INNV
0.297
+0.027
+10.000%
INO
9.27
+0.41
+4.63%
ISCO
1.81
-0.14
-7.18%
ISIS
57.56
0.00
0.00%
LGND
103.41
-0.14
-0.14%
LPTN
2.62
-0.13
-4.73%
MBVX
5
-0.07
-1.38%
MEIP
1.9
-0.01
-0.52%
MNOV
6.08
-0.09
-1.46%
MRTX
5.21
+0.12
+2.36%
MSTX
0.407
+0.017
+4.359%
NBIX
49.31
-0.23
-0.46%
NUVA
64.81
+0.74
+1.15%
ONCS
1.685
-0.015
-0.882%
ONVO
3.91
+0.03
+0.77%
OREX
3.83
-0.02
-0.52%
OTIC
16.19
+0.18
+1.12%
QDEL
21.73
+0.14
+0.65%
RCPT
231.96
0.00
0.00%
RGLS
3.24
0.00
0.00%
RMD
67.9
-1.13
-1.64%
SPHS
3.37
-0.15
-4.26%
SRNE
6.53
-0.09
-1.36%
TROV
5.01
+0.01
+0.20%
VICL
3.9
-0.09
-2.26%
VOLC
18
0.00
0.00%
ZGNX
9.33
+0.04
+0.43%
ACAD
32.62
-0.24
-0.73%
AEMD
5.21
-0.09
-1.70%
APRI
0.35
+0.01
+2.94%
ARNA
1.6
-0.03
-1.84%
ATEC
3.83
+0.14
+3.74%
CNAT
2
+0.1
+5.26%
CRXM
0.17
0.00
-1.52%
CYTX
2.06
+0.01
+0.49%
DXCM
91.65
+0.41
+0.45%
GNMK
8.64
-0.11
-1.26%
HALO
9.8
-0.02
-0.20%
ILMN
170.42
-1.79
-1.04%
INNV
0.297
+0.027
+10.000%
INO
9.27
+0.41
+4.63%
ISCO
1.81
-0.14
-7.18%
ISIS
57.56
0.00
0.00%
LGND
103.41
-0.14
-0.14%
LPTN
2.62
-0.13
-4.73%
MBVX
5
-0.07
-1.38%
MEIP
1.9
-0.01
-0.52%
MNOV
6.08
-0.09
-1.46%
MRTX
5.21
+0.12
+2.36%
MSTX
0.407
+0.017
+4.359%
NBIX
49.31
-0.23
-0.46%
NUVA
64.81
+0.74
+1.15%
ONCS
1.685
-0.015
-0.882%
ONVO
3.91
+0.03
+0.77%
OREX
3.83
-0.02
-0.52%
OTIC
16.19
+0.18
+1.12%
QDEL
21.73
+0.14
+0.65%
RCPT
231.96
0.00
0.00%
RGLS
3.24
0.00
0.00%
RMD
67.9
-1.13
-1.64%
SPHS
3.37
-0.15
-4.26%
SRNE
6.53
-0.09
-1.36%
TROV
5.01
+0.01
+0.20%
VICL
3.9
-0.09
-2.26%
VOLC
18
0.00
0.00%
ZGNX
9.33
+0.04
+0.43%
Home » Archive by Category

NYSE:PFE

Lpath Granted Two Additional U.S. Patents Related to iSONEP and ASONEP Drug Programs

October 5, 2011 – 5:31 am

SAN DIEGO, CA–(Marketwire – Oct 5, 2011) – Lpath, Inc. (OTCBB: LPTN), the industry leader in lipidomics-based antibody therapeutics, received official notification from the U.S. Patent and Trademark Office (USPTO) that Lpath has been issued two fur…